Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d57c7fa9be8bb4f0a1cd3286f2688ba4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56a71cdb708ba68a18d661fb7072cb6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 |
filingDate |
2009-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_236d9aad18639fa032ca1b67c64ad54c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1494abddf2d568d73839b38d5ae7fdff |
publicationDate |
2013-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8481760-B2 |
titleOfInvention |
Inhibition and treatment of prostate cancer metastasis |
abstract |
The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10780076-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11639340-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10231949-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11225483-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9839625-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11174238-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11691958-B2 |
priorityDate |
2008-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |